Bangladesh Said Yes to a Probe While the Toll Stayed at 424
Dhaka has agreed to investigate the procurement decision that killed 424 children — a decision that still has no public author.
Life
NEJM Published Daraxonrasib and Its Critic Published His Math the Same Week
The peer-reviewed paper landed on May 6. A peer of the principal investigators landed a denominator-tightening critique two days earlier.
Lake Powells 13 Percent Final Number Arrives With a Daily Flaming Gorge Release Schedule
The reservoir is on track for its worst summer inflow ever recorded — Thursday is when the federal back-up plan switches to a 1,100-cubic-feet-per-second baseline.
McGill Published Two Bone Papers in Nature This Week and One Finds a Fat-Burning Switch Too
One enzyme governs whether you burn fat for warmth and whether your bones harden — and the drug-screen pipeline is funded through 2029.
Brookings Quietly Built the Tracker for the Country That Stopped Growing
The Hamilton Project's labor tracker is now live, twice-monthly, with breakeven-growth math observable in near-real-time — and the institutions noticed.
A GLP-1 Trial in the Lancet Cut Heavy Drinking Days by Fourteen Points
108 patients, 26 weeks of semaglutide plus CBT yielded a 13.7-point cut in heavy drinking days — the first RCT supporting GLP-1 for alcohol use disorder.
Utah Measles Cases Are Slowing as the Out-of-State Map Keeps Widening
Utah at 663 cases — 37 in the last three weeks versus 121 in the prior three — while Travis County, Texas confirmed its first 2026 case on May 7 and Michigan now has 7 cases across four counties.
Microplastics Are Now a Short-Lived Climate Forcer and the IPCC Question Is Up
Coloured airborne plastic warms more than it cools — and the next IPCC assessment will have to decide whether to count it.
The CPC May Fourteenth ENSO Print Is the Super El Nino Decision Day
The CPC drops its monthly Diagnostic Discussion at noon today — the question is whether the 1-in-4 super-El-Nino probability moves up or holds.
Coffee Without Caffeine Still Reshapes the Microbiome and This Is the Rare RCT Design
A 62-person Cork RCT in Nature Communications — 14 days off coffee, then 21 days of caffeinated or decaf — shifted the gut similarly in both arms, implicating chlorogenic acids over caffeine.
Right Whale Season Closed at 23, the NOAA Write-Up Is Up, the Gulf Sighting Is in the Record
Twenty-three calves, the best season since 2009. The mom-calf pair sighted in the Gulf of America is now in the record.
The NOAA Atlantic Hurricane Outlook Is May Twenty-First and the Named Storm Count Is Zero
The 2026 outlook drops at 11 a.m. Eastern on May 21 with zero Atlantic named storms through today — and two new NHC products go with it.
The Tropical Forests Facility Cannot Pay Rainforests Until 2028, the Satellite Method Still Works
The 125-billion-dollar fund mechanism is built — but the first payments to rainforest countries will not arrive until 2028 at the earliest.
The FDA Approved an All-Oral AML Regimen This Morning and Inqovi Plus Venetoclax Is the First
Taiho's Inqovi plus venetoclax — FDA-approved May 13 for newly diagnosed AML in patients 75+ or otherwise ineligible for intensive induction — is the first all-oral combination for this population.
A CPS1 Deficiency Anniversary, the Custom Base-Edit Paper Is One Year On and Quiet
May 15 marks one year since the NEJM published the world's first personalized base-editing therapy — and the follow-up dataset is not yet public.
A CDC Thursday Print on Measles Is Expected and the May 7 Number Was 1,842
Atlanta's noon Thursday refresh meets a slowing Utah curve and a widening out-of-state map, with Travis County the new entry.
A Puppy Is Now the Name of an FDA-Cleared Blood Cancer Drug
Sonrotoclax (Beqalzi) got FDA accelerated approval May 13 for relapsed/refractory mantle cell lymphoma — the first BCL2 inhibitor for MCL and first new in the class in a decade.